Furiex Pharma reportedly seeking buyer, shares jump


Bloomberg reports Furiex Pharma (FURX +6.5%) has hired BofA/Merrill to help find a buyer. Shares have spiked higher in response.

Two weeks ago, Furiex more than doubled in response to news its Eluxadoline irritable bowel syndrome drug had met the company's main objectives in a late-stage study.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs